In this clinical trial, we demonstrate that ultrarapid fast infusion of rituximab (Truxima) in 30 min with oral premedication is feasible and secure for patients, and reduce the day-care hospital stays.
Keywords: cost‐efective; rituximab; ultrafast infusion.
© 2023 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.